
Memory Loss
Current Research Studies
If you are a patient and would like to enroll in a clinical trial, click here.
A Seamless Phase 2A-B Randomized Double-Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of BHV-4157 in Patients with Mild to Moderate Alzheimer's Disease PI: Tom Ala, MD Study Contact: Barbara Cray Lokaitis, BA, CCRP 217.545.9737 Not enrolling |
An Extension Study of ABBV-8E12 in Early Alzheimer's Disease PI: Tom Ala, MD Study Contact: Barbara Cray Lokaitis, BA, CCRP 217.545.9737 Not enrolling |
A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of MTAU9937A in Patients With Prodromal to Mild Alzheimer's Disease PI: Tom Ala, MD Study Contact: Stephanie Kohlrus, BA CCRP 217.545.2013 Not enrolling |
A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Gantenerumab in Patients With Early (Prodromal to Mild) Alzheimer's Disease - WN29922 PI: Tom Ala, MD Study Contact: Barbara Cray Lokaitis, BA, CCRP 217.545.9737 Not enrolling |
Caregiver Characteristics That May Predict When Patients With Alzheimer's Disease Are Placed in Long-term Care Facilities PI: Tom Ala, MD Study Contact: Stephanie Kohlrus, BA, CCRP 217.545.3013 Enrolling |
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer’s Disease, Phase III PI: Tom Ala, MD Study Contact: Chaille Karl, RN 217.545.2261 ENROLLING |